Literature DB >> 16398528

Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-L-phenylalanine copolymers.

Takami Akagi1, Mariko Higashi, Tatsuo Kaneko, Toshiyuki Kida, Mitsuru Akashi.   

Abstract

Amphiphilic graft copolymers consisting of poly(gamma-glutamic acid) (gamma-PGA) as the hydrophilic backbone and L-phenylalanine ethylester (L-PAE) as the hydrophobic side chain were synthesized by grafting L-PAE to gamma-PGA. The nanoparticles were prepared by a precipitation method, and about 200 nm-sized nanoparticles were obtained due to their amphiphilic properties. The hydrolytic and enzymatic degradation of these gamma-PGA nanoparticles was studied by gel permeation chromatography (GPC), scanning electron microscopy (SEM), dynamic light scattering (DLS) and (1)H NMR measurements. The hydrolysis ratio of gamma-PGA and these hydrophobic derivatives was found to decrease upon increasing the hydrophobicity of the gamma-PGA derivates. The pH had an effect on the hydrolytic degradation of the polymer. The hydrolysis of the polymer could be accelerated by alkaline conditions. The degradation of the gamma-PGA backbone by gamma-glutamyl transpeptidase (gamma-GTP) resulted in a dramatic change in nanoparticle morphology. With increasing time, the gamma-PGA nanoparticles began to decrease in size and finally disappeared completely. Moreover, the gamma-PGA nanoparticles were degraded by four different enzymes (Pronase E, protease, cathepsin B and lipase) with different degradation patterns. The enzymatic degradation of the nanoparticles occurred via the hydrolysis of gamma-PGA as the main chain and L-PAE as the side chain. In the case of the enzymatic degradation of gamma-PGA nanoparticles with Pronase E, the size of the nanoparticles increased during the initial degradation stage and decreased gradually when the degradation time was extended. Nanoparticles composed of biodegradable amphiphilic gamma-PGA with reactive function groups can undergo further modification and are expected to have a variety of potential pharmaceutical and biomedical applications, such as drug and vaccine carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16398528     DOI: 10.1021/bm050657i

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  9 in total

1.  Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles.

Authors:  Alberto Lanz-Landázuri; Montserrat García-Alvarez; José Portilla-Arias; Antxon Martínez de Ilarduya; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Chem Phys       Date:  2012-08-14       Impact factor: 2.527

2.  Nanoparticles of esterified polymalic acid for controlled anticancer drug release.

Authors:  Alberto Lanz-Landázuri; José Portilla-Arias; Antxon Martínez de Ilarduya; Montserrat García-Alvarez; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2014-06-06       Impact factor: 4.979

3.  Cellular delivery of PEGylated PLGA nanoparticles.

Authors:  Sarala Pamujula; Sidhartha Hazari; Gevoni Bolden; Richard A Graves; Dakshinamurthy Devanga Chinta; Srikanta Dash; Vimal Kishore; Tarun K Mandal
Journal:  J Pharm Pharmacol       Date:  2011-11-24       Impact factor: 3.765

4.  Induction of potent adaptive immunity by the novel polyion complex nanoparticles.

Authors:  Tomofumi Uto; Takami Akagi; Mitsuru Akashi; Masanori Baba
Journal:  Clin Vaccine Immunol       Date:  2015-03-25

5.  Ultrastable and Biofunctionalizable Gold Nanoparticles.

Authors:  Akash Gupta; Daniel F Moyano; Attasith Parnsubsakul; Alexander Papadopoulos; Li-Sheng Wang; Ryan F Landis; Riddha Das; Vincent M Rotello
Journal:  ACS Appl Mater Interfaces       Date:  2016-05-26       Impact factor: 9.229

Review 6.  Engineered nanomaterial uptake and tissue distribution: from cell to organism.

Authors:  Helene Kettiger; Angela Schipanski; Peter Wick; Jörg Huwyler
Journal:  Int J Nanomedicine       Date:  2013-08-27

7.  Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.

Authors:  Li Zhang; Tengteng Wang; Qiang Li; Jing Huang; Hao Xu; Jinlong Li; Yongjun Wang; Qianqian Liang
Journal:  Int J Nanomedicine       Date:  2016-06-08

8.  Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy.

Authors:  Enrique Niza; Cristina Nieto-Jiménez; María Del Mar Noblejas-López; Iván Bravo; José Antonio Castro-Osma; Felipe de la Cruz-Martínez; Marc Martínez de Sarasa Buchaca; Inmaculada Posadas; Jesús Canales-Vázquez; Agustín Lara-Sanchez; Daniel Hermida-Merino; Eduardo Solano; Alberto Ocaña; Carlos Alonso-Moreno
Journal:  Nanomaterials (Basel)       Date:  2019-08-27       Impact factor: 5.076

9.  A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.

Authors:  Ayimukedisi Yalikong; Xu-Quan Li; Ping-Hong Zhou; Zhi-Peng Qi; Bing Li; Shi-Lun Cai; Yun-Shi Zhong
Journal:  Int J Nanomedicine       Date:  2021-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.